|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Loans receivable, net of allowance for loan losses of $81,816 and $86,996, respectively | ||||||||||||||||||||
| Loans receivable at fair value | ||||||||||||||||||||
| Loans receivable | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Operating lease right of use assets | ||||||||||||||||||||
| Receivable from CSO lenders | ||||||||||||||||||||
| Receivable from payment processors | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Investment in unconsolidated affiliate | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Derivative assets at fair value (cost basis of $0 and $109, respectively) | ||||||||||||||||||||
| Assets from discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Accounts payable and accrued liabilities (See Note 13) | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Other taxes payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Notes payable, net (See Note 6) | ||||||||||||||||||||
| Liabilities from discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Preferred stock; $0.0004 par value; 24,500,000 authorized shares; none issued and outstanding at September 30, 2022 and December 31, 2021. | ||||||||||||||||||||
| Total preferred stock; $0.0004 par value; 24,500,000 authorized shares; none issued and outstanding at September 30, 2022 and December 31, 2021. | ||||||||||||||||||||
| Common stock; $0.0004 par value; 300,000,000 authorized shares; 44,960,438 and 44,960,438 issued; 31,218,030 and 31,810,759 outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock; at cost; 13,742,408 and 13,149,679 shares of common stock, respectively | ||||||||||||||||||||
| Retained earnings (Accumulated deficit) | ||||||||||||||||||||
| Accumulated other comprehensive income, net of tax benefit of $0 and $1,353, respectively | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
